Tightening of bio-manufacturing capacity expected to occur after 2024, whilst Europe forecast to equal North America in total capacity Amsterdam: The third part of the 2020 CPhI Annual Report – released during the second week of the CPhI Festival of Pharma (5-16 October, 2020) – predicts, that if approved, COVID vaccines and therapeutics will cause an impending biomanufacturing capacity
The post COVID-19 biologics will put huge pressure on large-scale bioprocessing networks appeared first on Pharma Mirror Magazine.
